PERIPHERAL BLOOD DNA METHYLATION BIOMARKERS ACCURATELY PREDICT CLINICAL- AND ENDOSCOPIC RESPONSE TO VEDOLIZUMAB IN A REAL-LIFE COHORT OF CROHNS DISEASE PATIENTS
Joustra VW., Hageman I., Li Yim AY., Levin E., Satsangi JJ., Adams A., De Jonge WJ., Henneman P., D'Haens GR.